§ 13-1103. Surveillance and Evaluation Component
West's Annotated Code of MarylandHealth--GeneralEffective: June 1, 2019
Effective: June 1, 2019
MD Code, Health - General, § 13-1103
§ 13-1103. Surveillance and Evaluation Component
(b) The purpose of the Surveillance and Evaluation Component is to:
(c)(1) To initiate the Surveillance and Evaluation Component, the Department shall conduct a comprehensive statewide Baseline Cancer Study as provided in this section.
(d) The Baseline Cancer Study shall measure:
(e) In order to maximize the cost effectiveness of the Baseline Cancer Study, the Department may use data in the Maryland Cancer Registry or provided by other sources, to the extent that these sources provide reliable data relating to the factors listed in subsection (d) of this section.
(f)(1) If the Department chooses to have a higher education institution or private entity conduct the Baseline Cancer Study or any part of the Study, the Department shall issue a request for proposal to select the entity that will conduct the Study or the relevant part of the Study.
(2) The request for proposal shall require that any methodology or model that is used by the entity to conduct the Baseline Cancer Study or the relevant part of the Study, any data collected under the Study, and any electronic files, codes, and definitions relating to the Study be provided to the State for use in subsequent studies, regardless of whether the studies are conducted by the same entity.
Credits
Added by Acts 2000, c. 17, § 1, eff. July 1, 2000; Acts 2000, c. 18, § 1, eff. July 1, 2000. Amended by Acts 2003, c. 203, § 1, eff. June 1, 2003; Acts 2019, c. 6, § 1, eff. June 1, 2019.
MD Code, Health - General, § 13-1103, MD HEALTH GEN § 13-1103
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |